UK study advocates once-only bowel cancer screening test
This article was originally published in Clinica
A colorectal cancer screening programme that offers patients a single sigmoidoscopy test at around the age of 60 years could dramatically reduce the number of deaths from the disease, a major UK study has revealed.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.